Recent Material Events - Seattle Genetics, Inc (SGEN)

Filing Date	Description
2008-07-08	“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Statements in this report regarding the Company’s business that are not historical facts are “forward-looking statements” that involve risks ...
2008-07-03	• The Lease, which was filed as an exhibit to the Company’s registration statement on Form S-1, File No. 333-50266, originally filed on November 20, 2000, as subsequently amended; and ...
2008-01-18	The information in this Current Report on Form 8-K under the heading Item 7.01, “Regulation FD Disclosure,” including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, ...
2008-01-14	In addition, the Company reported that it expects net cash used in operating activities in 2008 to range from $55 million to $65 million. This statement reflects the Company’s current views about future events and is subject to significant risks ...
2007-02-06	On February 6, 2007, Seattle Genetics, Inc. issued a press release announcing financial results for its fourth quarter and year ended December 31, 2006. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated into this Form... ...
2007-01-24	On January 22, 2007, the Compensation Committee of the Board of Directors of Seattle Genetics, Inc. (the “Company”) approved the 2007 Senior Executive Annual Bonus Plan (the “Plan”), an incentive compensation program, which is des... ...
2007-01-08	On January 7, 2007, Seattle Genetics, Inc. (the “Company”) entered into a collaboration agreement with Agensys, Inc. (“Agensys”) to jointly research, develop and commercialize antibody-drug conjugate (ADC) therapies for cancer. Th... ...
2007-01-08	On January 7, 2007, Seattle Genetics, Inc. (the “Company”) entered into an exclusive worldwide license agreement with Genentech, Inc. (“Genentech”) for the development and commercialization of SGN-40 (the “Genentech Agreement... ...
2006-10-24	The information included under Item 2.02 of this report is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Se... ...